Philippe Serrano, Pharm.D., is the Chief Regulatory Officer at Tango Therapeutics, leading regulatory affairs and patient safety. He brings more than 30 years of experience in global drug development and regulatory affairs to Tango.

Most recently, Philippe served as Senior Vice President at MorphoSys, overseeing global regulatory affairs, patient safety, clinical pharmacology, toxicology and medical writing. Prior to that, he worked at EMD Serono, Inc./Merck KGaA, Nicox, Aventis Pharmaceuticals (now Sanofi) and Baxter International, Inc.

Philippe received a Doctor of State in Pharmacy, an advanced research degree in pharmacotoxicology and a Master of Biological and Medical Sciences from the University of Montpellier, France, including managerial degrees from the Conservatoire national des arts et métiers (Le Cnam), Paris, France.